You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
Supreme Court Gene Ruling Benefits Biotech, Breast Cancer Research [USA]
Author: Megan McGrath, Voice of America, Published on: 13 June 2013
Everyone has BRCA genes in their cells. If you are a woman and one of your BRCA gene copies has a mutation, your risk of developing breast cancer is very high - up to 87 percent in some cases…Myriad Genetics Inc. was the first to discover the healthy, normal code of BRCA. Myriad developed [a breast cancer] test, and won patent protection for it and the original BRCA gene. Thursday, in a case against Myriad by the ACLU, the Supreme Court decreed that genes can no longer be patented, invalidating Myriad’s intellectual claim to the BRCA code…According to Dr. Marisa Weiss,…this could mean new research, cures and testing for women with BRCA mutations, and for cancer patients.
Related companies: Myriad Genetics